M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Indevus Pharmaceuticals Inc reports receipt of US Patent for SANCTURA XR
Indevus Pharmaceuticals Inc (Nasdaq: IDEV), a specialty pharmaceutical company, declared on 13 August the issuance of US Patent No. 7,410,978 (978 patent), entitled "Once Daily Dosage Forms of Trospium". The patent has been granted for a term of 20 years plus 89 days from its filing date of 4...
If you want to view the full text of this story, you must first purchase archive retrieval credits.